Shin Fujisawa

7PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Jul 05, 2024
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta

|Feb 08, 2024
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis.

Takashi Toya, Kota Mizuno, Masatoshi Sakurai

|Feb 05, 2024
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.

Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa

|Jan 20, 2017
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.

Shin Fujisawa, Shuichi Mizuta, Hideki Akiyama

Pageof 2

Frequent Collaborators

4 joint publications

Itaru Matsumura

4 joint publications

Emiko Sakaida

3 joint publications

Naoto Takahashi

3 joint publications

Takaaki Ono